London calling logo

London Calling 2024 - Speakers

Speakers

Subscribe

Check out the line up of speaking at London Calling 2024.

Oxford Nanopore Technologies

Dr. Gaia Nebbia

Gaia Nebbia
Job title
Institution
Guy's and St Thomas' NHS Foundation Trust UK
Biography

Dr. Gaia Nebbia, MBBSeq, MRCP, FRCPath, PhD, trained in virology and infectious diseases in London and completed her PhD in virology in 2008. Subsequently, she pursued further research in the field of viral immunology as an NIHR clinical lecturer. In 2015, Gaia joined Guy’s & St Thomas’ Hospital as a consultant virologist and in 2019, she was awarded the MRC Clinical Academic Research Partnerships grant to spearhead the development of real-time nanopore influenza sequencing and to conduct studies on influenza vaccine efficacy. Additionally, Gaia played a key role in implementing a whole-genome sequencing service for SARS-CoV-2 and respiratory metagenomics.

Recent publications

Snell, L.B. et al. Real-time whole genome sequencing to guide patient-tailored therapy of severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 76(6):1125–1128 (2023). DOI: 10.1093/cid/ciac864

Williams, T.G.S. et al. Feasibility and clinical utility of local rapid nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance. Microb Genom. 9(8) (2023). DOI: https://doi.org/10.1099/mgen.0.001083

Charalampous, T. et al. Routine metagenomics service for intensive care unit patients with respiratory infection. Am J Respir Crit Care Med. 209(2):164–174 (2023). DOI: 10.1164/rccm.202305-0901OC.

Talks at this conference